Otofarma S.p.A. (OTO.MI)
Otofarma S.p.A. operates in the Medical - Devices industry of the Healthcare sector, headquartered in Napoli, NA, IT. The stock last traded at $2.50, up 0.00% on the session, giving a market capitalisation of $14.9M. Its beta of -0.38 implies it has historically moved less than the broad market.
Otofarma S.p.A. specializes in the manufacturing and distribution of bespoke hearing solutions. The company's comprehensive product range includes custom-fit, in-the-canal (ITC), and behind-the-ear (BTE) hearing aids, along with rechargeable options and various essential accessories. Founded in 2016, the firm's main office is located in Napoli, Italy, complemented by another branch in Milan. Effective August 5, 2025, Otofarma S.p.A. will function as a subsidiary of Bartolomucci Holding s.r.l.